How to Manage Self-Poisoning With Baclofen in Alcohol Use Disorder? Current Updates

被引:5
作者
Franchitto, Nicolas [1 ,2 ,3 ]
Rolland, Benjamin [4 ,5 ]
Pelissier, Fanny [2 ]
Simon, Nicolas [6 ]
机构
[1] Toulouse Purpan Univ Hosp, Dept Addict Med, Toulouse, France
[2] Toulouse Purpan Univ Hosp, Poison Control Ctr, Toulouse, France
[3] Paul Sabatier Univ, UMR 1027, Toulouse, France
[4] SUAL, Pole MOPHA, CH Le Vinatier, Bron, France
[5] Univ Lyon, INSERM, U1028, UCBL,CRNL,CNRS,UMR5292, Lyon, France
[6] Aix Marseille Univ, Hop St Marguerite, AP HM, INSERM,CAP TV,IRD,SESSTIM,Serv Pharmacol Clin, Marseille, France
来源
FRONTIERS IN PSYCHIATRY | 2018年 / 9卷
关键词
baclofen; intoxication/pharmacology; comorbid conditions; seizures; psychiatry; HIGH-DOSE BACLOFEN; EXTRACORPOREAL TREATMENT USEFUL; PLACEBO-CONTROLLED TRIAL; SYMPTOMS CASE-REPORT; DEPENDENT PATIENTS; DOUBLE-BLIND; EFFICACY; OVERDOSE; SAFETY; INTOXICATION;
D O I
10.3389/fpsyt.2018.00417
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Specialists in addiction medicine continue to debate whether baclofen is still indicated to treat alcohol use disorders in view of conflicting results as to its efficacy. This review summarizes current knowledge on self-poisoning with baclofen focusing of alcohol-use disorder in order to provide an overview of the reliable scientific knowledge on management of such an intoxication. Moreover, as alcohol-dependent patients experience many psychiatric co-morbidities, the risk in suicide attempt using baclofen seems real. Numerous studies have suggested that patients given daily-doses of baclofen higher than 80 mg/day are more likely to attempt suicides than others. Following an ingestion of a large amount of baclofen, central nervous system depression is usually observed. Seizures require the patient to be admitted in intensive care unit and should be treated like other toxicological seizures. Cardiac complications include prolonged QTc interval, degree heart block, premature atrial contractions, and supraventricular tachycardia, hypotension and bradycardia. In cases of intoxication, the elimination half-life of baclofen may last between 12 and 36 h post-overdose and renal failure is known to delay its clearance. Rarely measured in clinical practice, the toxic level of baclofen blood level ranges from 1.1 to 3.5 mg/l, and coma or fatal intoxication are observed from 6 to 9.6 mg/l. Baclofen withdrawal has been observed but making the diagnosis of withdrawal in case of suspected self-poisoning is difficult as baclofen intoxication and baclofen withdrawal share many clinical signs. Admission to hospital to manage of suicide attempt with baclofen is mandatory and should not be limited to baclofen alone. It needs to include other aspects of the overall care of patients with alcohol disorders (psychological and psychosocial interventions, management of comorbid mental conditions and physical complications).
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Creating a new problem: The use of baclofen in the management of alcohol use disorder
    Akosile, Wole
    Klan, Matthew
    DRUG AND ALCOHOL REVIEW, 2016, 35 (01) : 115 - 116
  • [22] Baclofen in alcohol use disorder: An analysis of the data provided by the French "Temporary Recommendation for Use" 2014-2017 cohort
    de Beaurepaire, Renaud
    Rolland, Benjamin
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [23] Self-poisoning: current trends and practice in a UK teaching hospital
    Cook, Ronald
    Allcock, Rebecca
    Johnston, Michael
    CLINICAL MEDICINE, 2008, 8 (01) : 37 - 40
  • [24] Severity of Baclofen Self-Poisoning Linked to Psychiatric Co-morbidity in Alcohol-Dependent Patients: Better Measurement of Risk and Benefit
    Pelissier, Fanny
    de Haro, Luc
    Rolland, Benjamin
    Franchitto, Nicolas
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (04) : 217 - 219
  • [25] A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic
    Owens, Lynn
    Thompson, Andrew
    Rose, Abi
    Gilmore, Ian
    Pirmohamed, Munir
    Richardson, Paul
    ALCOHOL, 2017, 62 : 11 - 15
  • [26] Pharmacotherapy for Alcohol Use Disorder: Current and Emerging Therapies
    Swift, Robert M.
    Aston, Elizabeth R.
    HARVARD REVIEW OF PSYCHIATRY, 2015, 23 (02) : 122 - 133
  • [27] Baclofen-Associated Onset of Central Sleep Apnea in Alcohol Use Disorder: A Case Report
    Perogamvros, Lampros
    Pepin, Jean Louis
    Thorens, Gabriel
    Megevand, Pierre
    Claudel, Elisabeth
    Espa, Fabrice
    Besson, Marie
    Cervena, Katerina
    Janssens, Jean-Paul
    Lador, Frederic
    RESPIRATION, 2015, 90 (06) : 507 - 511
  • [28] Alcohol use disorders and previous history of deliberate self-poisoning are associated with greater degree of toxicity in deliberate self-poisonings
    Wiegand, Timothy J.
    Gorodetsky, Rachel A.
    Conner, Kenneth R.
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 634 - 634
  • [29] A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder
    de Beaurepaire, Renaud
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [30] Use of benzodiazepines in the general population and their involvement in acute self-poisoning cases
    Verstraete, AG
    Buylaert, WA
    Blondeel, L
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1998, 7 (06) : 403 - 410